xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 39007 | 19 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LQVLDSHYQDVLKEVKAAASK | 21 | null | 2,477 | 2,497 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324466 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 23561 | 20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | HARKAVTHINSVWKDLLEDN | 20 | null | 2,531 | 2,550 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324468 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 5561 | 21 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AVTHINSVWKDLLEDNVTPI | 20 | null | 2,535 | 2,554 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324469 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 47139 | 22 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PDLGVRVCEKMALYDV | 16 | null | 2,583 | 2,598 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324484 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 3 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 41086 | 23 | FragmentOfANaturalSequenceMolecule | Peptide from protein | MALYDVVTKLPLAVM | 15 | null | 2,593 | 2,607 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324485 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 50353 | 24 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QARVAIKSLTERLYVG | 16 | null | 2,668 | 2,683 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324486 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 4439 | 25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASGVLTTSCGNTLTCYIKA | 19 | null | 2,701 | 2,719 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324491 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 70546 | 27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VQEDAASLRAFTEAMTRYSA | 20 | null | 2,749 | 2,768 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324493 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 53104 | 28 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RAFTEAMTRYSAPPGDPPQP | 20 | null | 2,757 | 2,776 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324502 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 1 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 24965 | 29 | FragmentOfANaturalSequenceMolecule | Peptide from protein | HTPVNSWLGNIIM | 13 | null | 2,822 | 2,834 | 11104 | P26664.3 | null | Epitope containing region/antigenic site | Not determined | TCell | 1324503 | 67 | Table 3 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 2 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 77 | 26.01 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AACRAAGL | 8 | null | 2,721 | 2,728 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324513 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 168 | 26.02 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AAGLQDCT | 8 | null | 2,725 | 2,732 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324514 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 169 | 26.03 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AAGLQDCTM | 9 | null | 2,725 | 2,733 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324515 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 171 | 26.05 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AAGLQDCTMLV | 11 | null | 2,725 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324560 | 67 | Figure 1 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 2 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 171 | 26.05 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AAGLQDCTMLV | 11 | null | 2,725 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324517 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 21079 | 26.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLQDCTMLV | 9 | null | 2,727 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324556 | 67 | Figure 1 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 21079 | 26.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLQDCTMLV | 9 | null | 2,727 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324544 | 67 | Table 3 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 21079 | 26.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLQDCTMLV | 9 | null | 2,727 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324635 | 67 | Table 3 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Not determined | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 21079 | 26.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLQDCTMLV | 9 | null | 2,727 | 2,735 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324526 | 1 | Table 4 | Positive-High | true | 23.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 53059 | 26.07 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RAAGLQDCT | 9 | null | 2,724 | 2,732 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324527 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 53060 | 26.08 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RAAGLQDCTM | 10 | null | 2,724 | 2,733 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324528 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 53061 | 26.09 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RAAGLQDCTML | 11 | null | 2,724 | 2,734 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324529 | 417 | Table 4 | Negative | false | 50000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 74798 | 1073.07 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLLPRRGPRL | 10 | null | 35 | 44 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324618 | 67 | Table 5 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 74798 | 1073.07 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLLPRRGPRL | 10 | null | 35 | 44 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324636 | 67 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Not determined | Not determined | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 74798 | 1073.07 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLLPRRGPRL | 10 | null | 35 | 44 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324596 | 1 | Table 5 | Positive-Intermediate | true | 125.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 9203 | 1013.1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324619 | 67 | Table 5 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 9203 | 1013.1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324637 | 67 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Not determined | Not determined | null | 4 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 9203 | 1013.1 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324598 | 1 | Table 5 | Positive-Intermediate | true | 80.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 2901 | 1013.12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALSTGLIHL | 9 | null | 684 | 692 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324621 | 67 | Table 5 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 2901 | 1013.12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALSTGLIHL | 9 | null | 684 | 692 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324606 | 1 | Table 5 | Positive-Intermediate | true | 312.5 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 16725 | 1090.18 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLLLADARV | 9 | null | 723 | 731 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324622 | 67 | Table 5 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 16725 | 1090.18 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLLLADARV | 9 | null | 723 | 731 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324607 | 1 | Table 5 | Positive-High | true | 17.9 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 74961 | 1013.02 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324623 | 67 | Table 5 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 74961 | 1013.02 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLVAYQATV | 9 | null | 1,585 | 1,593 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324608 | 1 | Table 5 | Positive-Intermediate | true | 59.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 37286 | 1073.05 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLFNILGGWV | 10 | null | 1,807 | 1,816 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324633 | 67 | Table 3 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Not determined | Not determined | null | 8 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 37286 | 1073.05 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLFNILGGWV | 10 | null | 1,807 | 1,816 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324624 | 67 | Table 5 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 8 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 37286 | 1073.05 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLFNILGGWV | 10 | null | 1,807 | 1,816 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324609 | 1 | Table 5 | Positive-High | true | 4.2 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 26954 | 1073.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324625 | 67 | Table 5 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 1 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 26954 | 1073.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324639 | 67 | figure 4 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Not determined | Not determined | null | 1 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 26954 | 1073.06 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILAGYGAGV | 9 | null | 1,851 | 1,859 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324610 | 1 | Table 5 | Positive-Intermediate | true | 115.5 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 54605 | 1090.22 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLIVFPDLGV | 10 | null | 2,578 | 2,587 | 11104 | P26664.3 | null | Exact Epitope | Not determined | TCell | 1324626 | 67 | Table 5 | Negative | false | null | 9606 | null | null | DOID:1883 | 143 | null | PBMC | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 2 |
200043.xml | 200043 | 2025-11-06-08:00 | 7884894 | 1,995 | Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. | Journal of virology | M Battegay; J Fikes; A M Di Bisceglie; P A Wentworth; A Sette; E Celis; W M Ching; A Grakoui; C M Rice; K Kurokohchi | 54605 | 1090.22 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RLIVFPDLGV | 10 | null | 2,578 | 2,587 | 11104 | P26664.3 | null | Exact Epitope | Not determined | MhcBinding | 1324611 | 1 | Table 5 | Positive-Intermediate | true | 56.7 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201832 | 1 | Table 1 | Positive-Intermediate | true | 154.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201831 | 1 | Table 1 | Positive-Intermediate | true | 147.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201835 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201828 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201830 | 417 | Table 1 | Positive-Low | true | 2272.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201834 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201836 | 417 | Table 1 | Positive-Low | true | 1430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201829 | 1 | Table 1 | Positive-Intermediate | true | 250.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201833 | 417 | Table 1 | Positive-Low | true | 1820.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 8628 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DIEKKIAKMEKASSVFNVVNS | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201827 | 1 | Table 1 | Positive-High | true | 17.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201845 | 1 | Table 2 | Positive-Intermediate | true | 110.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201848 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201844 | 1 | Table 2 | Positive-Intermediate | true | 400.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201849 | 1 | Table 2 | Positive-Intermediate | true | 700.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201850 | 1 | Table 2 | Positive-Intermediate | true | 577.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201847 | 417 | Table 2 | Positive-Low | true | 1038.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 28673 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | ISQAVHAAHAEINE | 14 | null | 324 | 337 | 9031 | AAA48998.1 | null | Exact Epitope | Not determined | MhcBinding | 201846 | 417 | Table 2 | Positive-Low | true | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201859 | 1 | Table 1 | Positive-High | true | 31.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201852 | 1 | Table 1 | Positive-High | true | 69.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201857 | 417 | Table 1 | Positive-Low | true | 9790.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201853 | 1 | Table 1 | Positive-Intermediate | true | 141.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201855 | 1 | Table 1 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201858 | 1 | Table 1 | Positive-High | true | 8.2 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201854 | 1 | Table 1 | Positive-High | true | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201851 | 1 | Table 1 | Positive-High | true | 0.89 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 38561 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LPKPPKPVSKMRMATPLLMGALPM | 24 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | MhcBinding | 201856 | 1 | Table 1 | Positive-Intermediate | true | 444.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201863 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201862 | 1 | Table 2 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201861 | 417 | Table 2 | Positive-Low | true | 1222.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201860 | 417 | Table 2 | Positive-Low | true | 7000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201866 | 417 | Table 2 | Positive-Low | true | 3750.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201865 | 417 | Table 2 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 46072 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDGSTDYGILQINSR | 16 | null | 46 | 61 | 9031 | 1LKS_A | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201864 | 417 | Table 2 | Positive-Low | true | 8500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201871 | 1 | Table 1 | Positive-Intermediate | true | 676.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201868 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201872 | 1 | Table 1 | Positive-Intermediate | true | 263.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201874 | 417 | Table 1 | Positive-Low | true | 2765.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201875 | 1 | Table 1 | Positive-Intermediate | true | 211.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201870 | 1 | Table 1 | Positive-Intermediate | true | 505.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201867 | 1 | Table 1 | Positive-High | true | 70.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201869 | 1 | Table 1 | Positive-High | true | 85.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 47833 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PHHTALRQAILCWGELMTLA | 20 | null | 50 | 69 | 10408 | P03148.3 | null | Epitope containing region/antigenic site | Not determined | MhcBinding | 201873 | 1 | Table 1 | Positive-High | true | 9.1 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201876 | 1 | Table 1 | Positive-High | true | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201883 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201877 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201881 | 1 | Table 1 | Positive-Intermediate | true | 118.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201878 | 1 | Table 1 | Positive-High | true | 45.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201882 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201879 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201884 | 417 | Table 1 | Positive-Low | true | 2200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201880 | 1 | Table 1 | Positive-Intermediate | true | 385.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 48237 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 322 | 334 | 385630 | ABF83447.1 | null | Exact Epitope | Representative selection | MhcBinding | 201885 | 1 | Table 1 | Positive-High | true | 45.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201892 | 417 | Table 1 | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201886 | 1 | Table 1 | Positive-High | true | 52.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201890 | 1 | Table 1 | Positive-High | true | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201891 | 1 | Table 1 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201895 | 1 | Table 1 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200044.xml | 200044 | 2024-06-20-07:00 | 7895164 | 1,994 | Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Immunity | J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette | 52929 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYIKANSKFIGITE | 14 | null | 830 | 843 | 1513 | P04958.2 | null | Exact Epitope | Not determined | MhcBinding | 201887 | 417 | Table 1 | Positive-Low | true | 3623.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.